|Year : 2019 | Volume
| Issue : 4 | Page : 342-346
Medication adherence in first-episode psychosis and its association with psychopathology
Vijaya Raghavan1, Greeshma Mohan2, Subhashini Gopal2, Mangala Ramamurthy1, Thara Rangaswamy1
1 Consultant Psychiatrist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India
2 Psychologist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India
Background: The purpose of the study was to follow-up the individuals with first-episode psychosis (FEP) for a period of 1 year to assess their medication adherence rates and to identify the association between medication adherence and psychopathology.
Materials and Methods: In a 1 year longitudinal study, 59 individuals with FEP were assessed for their sociodemographic profile and medication adherence at 1 month and 12-month follow-up period using a semi-structured per forma. Positive and negative symptoms were assessed by positive and negative syndrome scale (PANSS) while the functioning by global assessment of functioning (GAF) scale.
Results: Nearly 85% of the individuals were adherent with medications during the 1-month follow-up period, 32.2% were poorly adherent at the end of 12 months. Among various factors examined for association with medication adherence, positive and negative symptoms, and global functioning of the individuals at the end of 12 months were found to significant associated with poor medication adherence.
Conclusion: There is a high rate of medication nonadherence in individuals with FEP at 12-month follow-up, and factors affecting nonadherence should be addressed specifically to improve medication adherence in these individuals.
Dr. Vijaya Raghavan
Schizophrenia Research Foundation, R/7A, North Main Road, Anna Nagar West Extension, Chennai - 600 101, Tamil Nadu
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*